DAJTI, ELTON
 Distribuzione geografica
Continente #
AS - Asia 6.947
NA - Nord America 4.301
EU - Europa 2.928
AF - Africa 404
SA - Sud America 352
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.940
Nazione #
US - Stati Uniti d'America 4.208
VN - Vietnam 1.995
SG - Singapore 1.764
CN - Cina 1.702
IT - Italia 974
HK - Hong Kong 458
DE - Germania 363
KR - Corea 294
GB - Regno Unito 279
BR - Brasile 259
SE - Svezia 256
IN - India 251
NL - Olanda 212
FR - Francia 162
JP - Giappone 136
IE - Irlanda 119
FI - Finlandia 103
CI - Costa d'Avorio 101
ZA - Sudafrica 99
RU - Federazione Russa 88
SC - Seychelles 79
CH - Svizzera 66
ID - Indonesia 54
ES - Italia 53
BG - Bulgaria 44
PH - Filippine 44
TG - Togo 42
CA - Canada 41
AT - Austria 38
TR - Turchia 38
BD - Bangladesh 37
TH - Thailandia 37
NG - Nigeria 36
MX - Messico 31
UA - Ucraina 31
AR - Argentina 28
PL - Polonia 27
PK - Pakistan 23
BE - Belgio 22
EC - Ecuador 22
JO - Giordania 20
IQ - Iraq 19
TW - Taiwan 18
EG - Egitto 13
VE - Venezuela 12
PT - Portogallo 11
AL - Albania 10
CO - Colombia 10
EE - Estonia 10
GR - Grecia 10
LT - Lituania 10
SA - Arabia Saudita 9
CL - Cile 8
CZ - Repubblica Ceca 8
KE - Kenya 8
AU - Australia 7
CR - Costa Rica 7
HR - Croazia 6
IR - Iran 6
PE - Perù 5
RS - Serbia 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
KZ - Kazakistan 4
LB - Libano 4
MA - Marocco 4
MK - Macedonia 4
PY - Paraguay 4
BO - Bolivia 3
MY - Malesia 3
NP - Nepal 3
RO - Romania 3
TN - Tunisia 3
AO - Angola 2
BB - Barbados 2
CM - Camerun 2
DZ - Algeria 2
ET - Etiopia 2
GA - Gabon 2
GH - Ghana 2
HU - Ungheria 2
IL - Israele 2
JM - Giamaica 2
KG - Kirghizistan 2
LV - Lettonia 2
MM - Myanmar 2
MT - Malta 2
OM - Oman 2
SN - Senegal 2
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BS - Bahamas 1
CY - Cipro 1
DK - Danimarca 1
GE - Georgia 1
GI - Gibilterra 1
GN - Guinea 1
HN - Honduras 1
Totale 14.921
Città #
Singapore 1.280
Hefei 591
Ashburn 570
Ho Chi Minh City 524
Hanoi 453
Fairfield 435
Hong Kong 408
San Jose 349
Bologna 269
Seoul 268
Chandler 253
Southend 185
Beijing 154
Dallas 153
Santa Clara 143
Los Angeles 137
New York 123
Dublin 117
Tokyo 102
Abidjan 101
Boardman 96
Council Bluffs 96
Da Nang 94
Milan 91
Seattle 87
Princeton 82
Lauterbourg 81
Houston 74
Haiphong 73
Johannesburg 73
Rome 73
Wilmington 69
Munich 67
Cambridge 66
Woodbridge 66
Bern 56
Bengaluru 55
Helsinki 55
Frankfurt am Main 52
São Paulo 46
Dong Ket 44
Buffalo 42
Lomé 42
Sofia 42
Turin 41
Redondo Beach 40
Amsterdam 36
Redmond 36
Abeokuta 33
Bremen 31
Guangzhou 31
Florence 30
Barcelona 29
Boydton 28
Shanghai 28
Ann Arbor 27
Berlin 26
Biên Hòa 26
Hải Dương 25
Turku 25
Bến Tre 24
Chicago 23
Des Moines 22
Nanjing 22
Brooklyn 21
Jakarta 21
Lappeenranta 21
Amman 20
Brussels 20
Bắc Ninh 20
Paris 20
San Diego 20
Tongling 20
Vienna 20
Warsaw 20
Hyderabad 19
London 19
Orem 19
Vũng Tàu 19
The Dalles 18
Tianjin 17
Falkenstein 16
Hangzhou 16
Quận Ba 16
San Francisco 16
Thái Bình 16
Wuhan 16
Bangkok 15
Chennai 15
Forlì 15
Montreal 15
Nha Trang 15
Phoenix 15
Washington 15
Atlanta 14
Medford 14
Stockholm 14
Can Tho 13
Denver 13
Nuremberg 13
Totale 9.436
Nome #
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 287
Monofocal hepatocellular carcinoma: How much does size matter? 283
A combined Baveno VII and spleen stiffness algorithm to improve the non-invasive diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease 247
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study 239
Pattern of macrovascular invasion in hepatocellular carcinoma 233
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 233
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 225
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study 220
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments 219
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 218
Sarcopenia evaluated by EASL/AASLD computed tomography-based criteria predicts mortality in patients with cirrhosis: A systematic review and meta-analysis 208
Clinical impact of sarcopenia assessment in patients with liver cirrhosis 208
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients 205
Pre-transplant psoas muscle density as a ready-to-use and low-cost predictor of patient survival after liver transplant 202
The changing scenario of hepatocellular carcinoma in Italy: an update 200
Kawasaki disease, multisystem inflammatory syndrome in children, and adenoviral infection: a scoring system to guide differential diagnosis 198
Sarcopenia predicts ascitic decompensation and mortality independently of portal hypertension status in patients with advanced chronic liver disease outside the liver transplantation setting 191
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 190
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 188
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 186
“Are the Expanded Baveno VI Criteria really safe to screen compensated cirrhotic patients for high-risk varices?” 186
Utility of Doppler-Ultrasound and Liver Elastography in the Evaluation of Patients with Suspected Pregnancy-Related Liver Disease 185
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure 182
The non‐invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study 180
Combination of fecal calprotectin and initial coronary dimensions to predict coronary artery lesions persistence in Kawasaki disease 175
Standard Bismuth Quadruple Therapy versus Concomitant Therapy for the First-Line Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 174
Systematic review with meta-analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults 174
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 172
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 172
Survival After Transarterial Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: An Updated Meta-analysis and Meta-regression 171
Adherence to European Society of Gastrointestinal Endoscopy Quality Performance Measures for Upper and Lower Gastrointestinal Endoscopy: A Nationwide Survey From the Italian Society of Digestive Endoscopy 170
Segmental Distribution of Hepatocellular Carcinoma in Cirrhotic Livers 168
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients 167
Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review 166
Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly 165
Advances in Endo-Hepatology: The Role of Endoscopic Ultrasound in the Management of Portal Hypertension 164
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients 156
Can Liver Ultrasound Elastography Predict the Risk of Hepatocellular Carcinoma Recurrence After Radiofrequency Ablation? A Systematic Review and Meta-Analysis 154
Autoimmune Atrophic Gastritis: A Clinical Review 154
Hierarchically Positioning Laparoscopic Microwave Ablation in the Therapeutic Span of Early Hepatocellular Carcinoma: A Real-Life Comparative Analysis 151
Approaches to the Diagnosis of Portal Hypertension: Non-Invasive or Invasive Tests? 150
Sarcopenia predict complications after hepatic resection for primary hepatocellular carcinoma (HCC) in patients with advanced chronic liver disease (ACLD) and clinically significant portal hypertension (CSPH) 148
Biliary Diseases from the Microbiome Perspective: How Microorganisms Could Change the Approach to Benign and Malignant Diseases 148
Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients 147
Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder 146
The Role of Microbiota in Upper Gastrointestinal Cancers 146
Spleen stiffness measurement predicts the development of primary hepatocellular carcinoma better than hepatic venous pressure gradient 145
Liver and Spleen Stiffness Measurements for Assessment of Portal Hypertension Severity in Patients with Budd Chiari Syndrome 144
Is Ultrasound Elastography Useful in Predicting Clinically Relevant Pancreatic Fistula After Pancreatic Resection?: A Systematic Review and Meta-analysis 144
Liver Measurement Stiffness Can Predict Chemotherapy-related Liver Injury and Complications after Surgery for Liver Metastases 142
Non-invasive diagnosis of clinically significant portal hypertension and treatment with non-selective beta-blockers: a new paradigm 141
Epidemiological, diagnostic, therapeutic and prognostic impact of hepatitis B and D virus infection on hepatocellular carcinoma: A review of the literature 139
The interplay between sarcopenia and portal hypertension predicts ascites and mortality in cirrhosis: Sarcopenia predicts ascites and death in cirrhotic patients 139
A spleen stiffness measurement-based model for recognition of high risk varices: Baveno VI criteria and beyond 139
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease 137
Clinical presentation of celiac disease and diagnosis accuracy in a single-center european pediatric cohort over 10 years 135
Corrigendum: Adherence to European society of gastrointestinal endoscopy quality performance measures for upper and lower gastrointestinal endoscopy: a nationwide survey from the Italian society of digestive endoscopy 134
HEPATIC DECOMPENSATION RISK IS REDUCED, BUT NOT ELIMINATED AFTER DIRECT-ACTING ANTIVIRALS: THE ROLE OF SPLEEN STIFFNESS MEASUREMENT 133
Predictive factors for hepatocellular carcinoma recurrence after curative treatments 133
Non-invasive tests for the prediction of primary hepatocellular carcinoma 130
New practice guidelines on risk stratification and management of portal hypertension: towards a personalized multidisciplinary approach 129
Porto-sinusoidal vascular disorder in surgical candidates for liver metastases: prevalence, non-invasive diagnosis, and burden on surgical outcomes 127
Idiopathic chronic intestinal pseudo-obstruction syndrome is strongly associated with low serum levels of vitamin D 126
Adherence to international guidelines for the management of Helicobacter pylori infection among gastroenterologists and gastroenterology fellows in Italy: A Survey of the Italian Federation of Digestive Diseases - FISMAD 125
Gut microbiota signatures and clinical manifestations in celiac disease children at onset: a pilot study 123
Prediction of posthepatectomy liver failure: Role of SSM and LSPS 119
Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients- UEG Week 2020 Poster Presentations 118
Validation of a standardized CT protocol for the evaluation of varices and porto-systemic shunts in cirrhotic patients 118
null 115
New insights on portal hypertension's screening in people with cystic fibrosis 114
Diagnostic Approach to Elevated Liver Function Tests during Pregnancy: A Pragmatic Narrative Review 111
Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients 109
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival 106
Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness 104
A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease 103
The role of liver and spleen elastography in advanced chronic liver disease 103
Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED) 99
Antibiotic prophylaxis in patients with cirrhosis: Current evidence for clinical practice 98
Sarcopenia Predicts Major Complications after Resection for Primary Hepatocellular Carcinoma in Compensated Cirrhosis 98
Reply to: Triple-phase CT scan for disease progression prediction in cirrhosis: A valid repurpose? 96
Ruolo e significato clinico dei metodi non invasivi nella valutazione dell’ipertensione portale nel paziente affetto da epatopatia cronica 95
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure 94
Validation of a standardized CT protocol for the evaluation of varices and porto-systemic shunts in cirrhotic patients 92
Hepatic encephalopathy and MELD-Na predict treatment benefit in autoimmune hepatitis-related decompensated cirrhosis 92
Minimally invasive hepatectomy vs. thermoablation for single small (≤3 cm) hepatocellular carcinoma: A weighted real-life national comparison 91
Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study 91
Trial sequential analysis of EUS-guided gallbladder drainage versus percutaneous cholecystostomy in patients with acute cholecystitis 88
Sarcopenia Predicts Major Complications after Resection for Primary Hepatocellular Carcinoma in Compensated Cirrhosis 88
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis 86
Covid-19 in a young liver transplant recipient: Caution for drug-drug interactions 84
null 83
Determinants of outcomes of transmural EUS-guided gallbladder drainage: systematic review with proportion meta-analysis and meta-regression 82
Non-invasive diagnosis of clinically significant portal hypertension and treatment with non-selective beta-blockers: a new paradigm 82
In-hospital Mortality in Patients with Lower Gastrointestinal Bleeding: Development and Validation of a Prediction Score 81
Diagnostic accuracy of FibroScan-AST (FAST) score for the non-invasive identification of patients with fibrotic non-alcoholic steatohepatitis: a systematic review and meta-analysis 76
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients 76
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular Carcinoma 71
Incidence and clinical significance of recompensation after HCV-cure 65
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study 62
Efficacy and safety of endoscopic ultrasound-guided hepaticogastrostomy: a meta-regression analysis 61
Totale 14.467
Categoria #
all - tutte 42.638
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.638


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021218 0 0 0 0 0 0 0 0 0 32 14 172
2021/20221.128 19 14 25 31 80 34 42 69 53 71 550 140
2022/20231.384 76 136 52 160 107 127 60 55 248 45 169 149
2023/2024667 41 94 58 65 58 167 27 34 25 44 31 23
2024/20252.713 108 245 209 194 261 129 238 111 60 288 283 587
2025/20268.368 821 1.025 770 705 650 326 1.429 404 1.636 602 0 0
Totale 15.280